Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer

Belinda Lee, Lara Lipton, Joshua D. Cohen, +22

Annals of Oncology

Surgical OncologyPancreatic CancerGastrointestinal OncologyMedicinePathology +7

Limitations in small intestinal neuroendocrine tumor therapy by mTor kinase inhibition reflect growth factor–mediated PI3K feedback loop activation via ERK1/2 and AKT

Bernhard Svejda, Mark Kidd, Alexander D. Kazberouk, +3

Cancer

A mechanistic role for the chromatin modulator, NAP1L1, in pancreatic neuroendocrine neoplasm proliferation and metastases

Simon Schimmack, Andrew Taylor, Ben Lawrence, +5

Epigenetics & Chromatin

Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer

Ben Lawrence, Cherie Blenkiron, Kate Parker, +33

npj Genomic Medicine

Serotonin and the 5‐<scp>HT</scp>7 receptor: The link between hepatocytes, <scp>IGF</scp>‐1 and small intestinal neuroendocrine tumors

Bernhard Svejda, Mark Kidd, Andrew T. Timberlake, +6

Cancer Science

PathologyTumor Biology5-Ht₇ Receptor ExpressionEndocrine OncologyHepatobiliary Tumor +14

A Clinical Perspective on Gastric Neuroendocrine Neoplasia

Ben Lawrence, Mark Kidd, Bernhard Svejda, +1

Current Gastroenterology Reports

MedicineNeuroendocrine DisorderGastroenterologySurgeryNeuroendocrine Tumors +1

Quality of life is not influenced by the extent of surgery in patients with benign goiter

Friedrich H. Schmitz-Winnenthal, Simon Schimmack, Ben Lawrence, +4

Langenbeck s Archives of Surgery

NursingQuality Of LifeSurgeryBenign Goiter

Unmet needs in the international neuroendocrine tumor (NET) community: Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals

Simone Leyden, Teodora Kolarova, Catherine Bouvier, +16

International Journal of Cancer

PDX1 DNA Methylation Distinguishes Two Subtypes of Pancreatic Neuroendocrine Neoplasms with a Different Prognosis

Gitta Boons, Timon Vandamme, Joe Ibrahim, +8

Cancers

Circulating tumor DNA is a sensitive marker for routine monitoring of treatment response in advanced colorectal cancer

Donghui Zou, Robert C. Day, Judy Ann Cocadiz, +8

Carcinogenesis

Dna AnalysisPathologyAdvanced Colorectal CancerNucleic Acid BiomarkersTumor Biology +15